… Jürg H Beer, MD Jürg H Beer … Beat Meyer, Bernhard Lämmle, Jürg Beer, and Walter
Wuillemin designed the study. Khatereh Moshfegh and Sabina Liechti-Gallati were involved in the …

Objective Drug-drug interaction (DDI) screening programs are an important tool to check
prescriptions of multiple drugs. The objective of the current study was to critically appraise …

Cardiovascular aging presents a formidable challenge, as the aging process can lead to
reduced cardiac function and heightened susceptibility to cardiovascular diseases. …

OBJECTIVE: The aim of this study was to assess potential drug–drug interactions (pDDIs) at
hospital admission, during hospitalization and at discharge and to evaluate the number of …

Aims We aimed to investigate the association of clinically overt and silent brain lesions with
cognitive function in atrial fibrillation (AF) patients. Methods and results We enrolled 1227 AF …

The existence of a phenomenon of rebound hypercoagulability after cessation of oral
anticoagulant therapy is controversial. The sensitive procoagulant markers for in vivo thrombin and …

There is a need to validate risk assessment tools for hospitalised medical patients at risk of
venous thromboembolism (VTE). We investigated whether a predefined cut-off of the Geneva …

Proprotein convertase subtilisin/Kexin 9 (PCSK 9) is revealed to be a key player in lipid
metabolism and, therefore, in the development and progression of atherosclerosis. PCSK 9 …

Objective— Plant-derived α-linolenic acid (ALA) may constitute an attractive cardioprotective
alternative to fish-derived n-3 fatty acids. However, the effect of dietary ALA on arterial …

Background— α-Linolenic acid (ALA) may protect from cardiovascular disease. Because
fresh alpine grass contains high amounts of ALA, we hypothesized that the levels of ω-3 fatty …